MedImmune Accused Of Stealing |Blockbuster HPV Vaccine Technology

     WILMINGTON, DEL. (CN) – MedImmune‘s human papillomavirus virus vaccine, Cervarix, will generate $2 billion a year and MedImmune plans to stiff the nonprofit Boyce Thompson Institute for Plant Research, which supplied it with the “high five cell line” technology that made the vaccine possible, Boyce Thompson claims in New Castle Superior Court.
     MedImmune, a subsidiary of AstraZeneca, stole and converted trade secrets, in breach of contract, and plans to sell the blockbuster drug with a partner, GlaxoSmithKline, says Boyce Thompson, which seeks punitive damages. See complaint.

%d bloggers like this: